Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cullinan Therapeutics

8.54
+0.26003.14%
Volume:342.03K
Turnover:2.85M
Market Cap:499.70M
PE:-2.74
High:8.58
Open:8.28
Low:8.07
Close:8.28
Loading ...
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 17, 2023

Correspondence

Form CORRESP - Correspondence
Mar 09, 2023

Correspondence

Form CORRESP - Correspondence
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2023

Major Issues Report

8-K - Current report